The heart was removed from mongrel dogs (15-25 kg) following anesthesia with sodium pentobarbital (30 mg/ kg, iv). The left circumflex coronary artery (approximately 4 cm long and 2.0 mm in outside diameter) was dissected free.
Inhibitors of Prostaglandin Synthesis Augment /?-Adrenergic Responsiveness in Canine Coronary Arteries
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From the Department of Physiology and Biophysics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota SUMMARY. The effects of inhibition of endogenous prostaglandin synthesis on the release of norepinephrine from sympathetic nerves and on postjunctional adrenergic responsiveness were studied in isolated canine left circumflex coronary arteries. In rings, suspended for isometric tension recording and contracted with prostaglandin F 2o , transmural electrical stimulation caused frequency-dependent relaxations, which were blocked by propranolol and augmented by indomethacin. In superfused strips, previously incubated with [ HJnorepinephrine, electrical stimulation (2 Hz) increased the overflow of tritiated neurotransmitter; indomethacin did not influence basal or evoked [ 3 H]norepinephrine overflow. Exogenous norepinephrine caused relaxations in rings contracted with prostaglandin F 2o , but increases in tension in potassium-depolarized tissues which could be abolished by phentolamine; isoproterenol induced relaxations in both cases. Indomethacin significantly augmented the relaxation in response to exogenous norepinephrine (during contractions with prostaglandin F 2(t ) and reversed norepinephrine-induced contractions (during potassium-depolarization) into relaxation. Other cyclooxygenase inhibitors had comparable effects. In the presence of propranolol, indomethacin did not diminish contractions evoked by norepinephrine in depolarized rings. Relaxations induced by sodium nitroprusside or acetylcholine during contractions caused by prostaglandin F 2<> or potassium chloride were not affected by indomethacin. The augmentation of ^-adrenergic responsiveness by indomethacin was abolished by exogenous prostacyclin. The prostacyclin synthetase inhibitor tranylcypromine and exogenous prostaglandin E2 depressed /3-adrenergic responsiveness. Indomethacin did not affect the facilitatory action of phosphodiesterase inhibition on /3-adrenergic relaxation. The data suggest that endogenous prostaglandins (most probably prostacyclin and prostaglandin E 2 ) exert a "braking" effect on /3-adrenergic responsiveness in coronary arterial smooth muscle. (Circ Res 56: 117-125, 1985) THE large coronary arteries of the canine heart contain adrenergic nerve terminals which release norepinephrine upon stimulation; under control conditions, the /3-adrenergic effect of the released transmitter predominates, causing relaxation (Borda et al., 1977; Rorie and Shepherd, 1980; Cohen et al., 1983) . The relaxations of the canine coronary artery induced by electrical stimulation of the adrenergic nerve endings or by the indirectly acting sympathomimetic amine, tyramine, are potentiated by the inhibitor of cyclooxygenase, indomethacin (Cohen et al., 1983) . These observations suggest that endogenously formed prostaglandins impair adrenergic neuroeffector interaction in this preparation by either decreasing the release of norepinephrine from the adrenergic nerve endings, by accelerating the disposition of the transmitter, by increasing a-adrenergic responsiveness of the vascular smooth muscle or by reducing /3-adrenergic relaxation. The present study demonstrates that inhibition of vascular prostaglandin synthesis augments the postjunctional /8-adrenergic responsiveness of coronary arterial smooth muscle.
Drugs
The following pharmacological agents were used: acetylsalycilic acid (aspirin, Sigma); indomethacin (Sigma); isobutyl-methylxanthine (IBMX; Sigma); d,/-isoproterenol (Sigma); sodium meclofenamate (Parke-Davis); sodium nitroprusside (Sigma); levo[7-3 H(N)]norepinephrine, specific activity: 2.7 Ci/mmol (New England Nuclear); /-norepinephrine bitartrate (Sigma); phentolamine mesylate (Ciba-Geigy); d,/-propranolol (Sigma), prostacyclin (PGI 2 , Sigma), prostaglandin E 2 (Sigma), prostaglandin F 2o (Sigma), and tranylcypromine sulfate (Smith, Kline and French Labs). Drugs were dissolved in distilled water such that volumes of less than 0.2 ml per dose were added to the organ chambers. The concentrations of drugs are expressed as final molar bath concentrations (M). Indomethacin was dissolved in 0.0005% Na 2 CO 3 . Blocking agents were added to the bath for at least 30 minutes prior to determining their effect on the response to agonists or electrical stimulation. The response of coronary rings in the presence of antagonists was always compared to that of a ring from the same vessel in which a response in the absence of antagonist was elicited simultaneously. To study relaxation, we contracted the rings with either prostaglandin F 2a (2 X 10" 6 M) or with KC1 (2 X 10"* M). Contractions reached a maximum in 6-8 minutes; in time control experiments, the plateau response to both agonists was linear for 40 minutes. Inhibitory responses to electrical stimulation or drugs were elicited after the plateau was reached and were expressed as percent of the contraction induced by prostaglandin F 2a or KG. ID 50 is the concentration of agonist causing 50% inhibition of these contractions. All vascular rings analyzed in the present study contained endothelial cells as they all relaxed to 10~7 M acetylcholine (Furchgott and Zawadzki, 1980) .
Electrical Stimulation
Adrenergic nerve endings of left circumflex coronary rings were stimulated electrically with parallel rectangular platinum electrodes (1 cm 2 , 7-mm spacing), a stimulator (Grass SD9) and a d.c. current amplifier. Since supramaximal transmural stimulation of coronary artery rings results in non-neurogenic inhibitory responses (Brine et al., 1979; Toda, 1981; Rooke et al., 1982) , the current-threshold for the non-neurogenic response was determined for each experiment. Rings were contracted with prostaglandin F 2o (2 X 10~6 M) in the presence of tetrodotoxin (10~7 M) and the maximal pulse duration (10 V, 16 Hz) which caused no relaxation was determined. After washout of tetrodotoxin, responses to these stimuli were then repeated after contraction with prostaglandin F 2(t (2 X 10 M); relaxations were expressed as percent of the response to prostaglandin F 2o . Frequency-response curves were obtained by allowing responses to reach maximum before increasing the frequency. The responses in the presence of indomethacin were obtained simultaneously with control responses in untreated rings from the same arteries.
[ 3 H]Norepinephrine Release by Electrical Stimulation
Longitudinal strips of left circumflex coronary artery (3-4 cm long, 2-3 mm wide, 34 ± 2.7 mg; n = 12) were incubated for 120 minutes in [ 3 H]norepinephrine (10~6 M). After incubation, the tissues were rinsed in fresh physiological salt solution, suspended at 4 g tension, and superfused, by means of a roller pump, with oxygenated physiological salt solution (3 ml/min; 37°C). For electrical stimulation, two platinum wires (0.3 mm in diameter, 10 Circulation Research/Vo/. 56, No. 1, January 1985 cm long) were placed parallel to and in contact with the strips. Electrical impulses were 10 V, 0.2 msec in duration (Vanhoutte et al., 1973; Cohen et al., 1983) .
After an initial washout period of 120 minutes, the superfusate was collected for 2-minute intervals (by means of a fraction collector) for estimation of the efflux of total radioactivity. Strips were electrically stimulated (Si) for 6 minutes at 2 Hz, followed by a 48-minute washout period during which tritium efflux reached basal levels. A second stimulation (S 2 ) was applied in the presence or absence of indomethacin (5 X 10 M). The effect of the cyclooxygenase inhibitor (applied 40 minutes before S 2 ) was expressed as the ratio between the overflow of tritium evoked by Si and the overflow evoked by S 2 .
Radioactivity Measurements
At trie end of the experiments with [ 3 H]norepinephrine, the strips were blotted dry, weighed, and the tritiated compounds were extracted with 1 N acetic acid containing 0.03 mM disodium EDTA and 5 mM ascorbic acid (Verbeuren et al., 1978; Verbeuren and Vanhoutte,1982) . Fractional release of tritiated compounds was calculated as the ratio of disintegrations per minute (dpm) released per unit time to the total dpm extracted plus dpm released.
To determine the amounts of intact [ 3 H]norepinephrine and its major metabolites in the superfusate, samples for column chromatographic analysis were obtained by pooling three of the 2-minute samples immediately before and after each period of electrical stimulation. In these samples, tritiated norepinephrine was separated from its major metabolites as described previously (Verbeuren et al., 1977 (Verbeuren et al., ,1978 . Evoked efflux of tritiated norepinephrine was calculated as stimulated minus basal efflux.
Samples (1 ml) of the incubation solutions, superfusate, the extraction medium, and the fractions obtained during the column chromatographic procedure were added to 10 ml scintillation fluid (Safety-Solve; Research Products International), and the radioactivity was measured in a liquid scintillation spectrometer (Beckman LS 6800); corrections for quenching were made by the external standard method. All samples were counted for 10 minutes or until 10,000 counts/min was reached.
Statistical Analysis
Unless otherwise noted, rings or strips from six animals were studied for each group of experiments. The data are expressed as means ± SEM. Statistical evaluation of the data was carried out by Student's two-tailed f-test. Differences were regarded as significant when P values were less than 0.05.
Results

Organ Bath Experiments
KC1 (2 X 10~2 M) produced significantly greater contractions (7.4 ± 0.9 g; n = 15; P < 0.01) than prostaglandin F 2Q (2 X 10~6 M) (3.9 ± 0.4 g; n = 16). In rings contracted with prostaglandin F 2a , transmural electrical stimulation caused frequency-dependent relaxation which could be inhibited by propranolol (10~6 M) ( Fig. 1) . Norepinephrine caused concentration-dependent relaxations in rings contracted with prostaglandin F 2a , and contractions in those exposed to KC1 (Figs. 2 and 3). Electrical stimulation, Hz
FIGURE 1. Effect of indomethacin and propranolol on transmural electrical stimulation (10 V; 0.25 msec) evoked relaxations of isolated canine left circumflex coronary arteries during prostaglandin F 2o (2 X 10' 6 M)-induced contractions. Each symbol represents the mean ± SEM of rings taken from six dogs. Control responses and those in the presence of antagonists were obtained simultaneously in separate rings from the same dog.
The addition of indomethacin (5 X 10~6 M) to the organ bath increased basal tension (by 0.91 ± 0.25 g; P < 0.05; n = 15) and augmented prostaglandin F 2a -induced contractions (from 3.5 ± 0.9 g to 7.3 ± 0.9 g; P < 0.01; n = 9). Indomethacin significantly augmented the relaxations due to electrical stimulation (in the 2-16 Hz frequency range; Fig. 1 ) and to norepinephrine (Figs. 2 and 3). Indomethacin did not influence the contractions evoked by KG (8.9 ± 0.9 g in the absence, and 9.3 ± 1.4 g in the presence of indomethacin; n = 9), but reversed the increases in tension caused by norepinephrine (10~8 to 3 X 10~6 M) during these contractions into relaxations; at higher concentrations (10~5 to 10~4 M) of norepinephrine, tension tended to return toward control values (Figs. 2 and 3). During contractions caused by prostaglandin F 2n and KG, sodium nitroprusside caused concentration-dependent relaxations, which were not affected by indomethacin during contractions evoked by prostaglandin F 2a (relaxations with 10~7 M sodium nitroprusside: 41.5 ± 4.1 and 41.8 ± 6.6% in the absence and presence of indomethacin, respectively) or KG (20.4 ± 2.9 and 17.1 ± 5.8%, respectively. The endothelium-dependent relaxations to acetylcholine were not affected by the cyclooxygenase inhibitor (data not shown).
Acetylsalicyclic acid (5 X 10~5 M) and sodium meclofenamate (10~5 M) increased basal tone (by 0.6 ± 0.2 g and 0.8 ± 0.2 g, respectively) and augmented prostaglandin F 2a -induced contractions (from 3.9 ± 0.2 to 7.1 ± 0.3 g and from 4.1 ± to 6.8 ± 0.4 g, respectively). In the presence of both drugs, the contractile responses to norepinephrine (3 X 10~8 to 3 X 10~6 M) were reversed to relaxation, whereas, at higher doses of the catecholamine, tension tended to return toward control values in KG-contracted rings (Fig. 4 ). Sodium meclofenamate augmented the isoproterenol-induced relaxations in a fashion similar to that of indomethacin, but acetylsalycilic acid caused significant augmentation of /S-adrenergic relaxations only at low concentrations (3 X 10~8-3 X 10~7 M) of isoproterenol ( Fig. 4) .
In the presence of phentolamine (10~5 M), norepinephrine evoked dose-dependent relaxations during contractions caused by KG ( Fig. 5 ). In the presence of propranolol (10~6 M), the increases in tension caused by norepinephrine during KG-induced responses were significantly greater ( Fig. 5 ) than those obtained in the absence of the /8-adrenergic blocker (Fig. 3 ). Phentolamine and propranolol did not significantly affect the KG-induced contraction. Isoproterenol relaxed preparations contracted with KG in a dose-dependent manner (ID 50 : 4.8 ± 1.2 X 10~7 M; maximal effect at 10~5 M concentration: 45 ± 9.2% relaxation); this relaxation was significantly inhibited by propranolol (10~6 M 
. Isometric tension recordings in rings of isolated canine coronary arteries. Responses to increasing concentrations of norepinephrine in the absence or presence of indomethacin during contractions with prostaglandin F 2a (upper two tracings) or with KG (lower two tracings). Indomethacin augmented relaxation induced by norepinephrine during prostaglandin Fia-evoked contractions, and reversed the response
to norepinephrine from contraction to relaxation in rings exposed to KCl. Norepinephrine, -log M contractions; the relaxations caused by 10 6 to 10 4 M norepinephrine were significantly greater than those observed in the presence of indomethacin alone (Fig. 5) . The augmentation by indomethacin of the relaxations induced by isoproterenol was not influenced by the presence of phentolamine (10~5 M; Fig. 5 ). In the presence of propranolol (10~6 M) and indomethacin, increasing doses of norepinephrine caused contractions which were significantly greater in the 3 X 10~6 to 10~4 M concentration range (Fig. 5 ) than those observed under control conditions (Fig. 3) , but similar to those obtained in the presence of propranolol alone (Fig. 5 ). Indomethacin augmented the relaxation induced by 10~4 M isoproterenol in the presence of the ^-adrenoceptor antagonist (Fig. 5) .
In another series (n = 5), four rings were studied in parallel; two were pretreated with 5 X 10~6 M indomethacin. After contraction with prostaglandin F 2 a (2 X 10~6 M), one control and one indomethacin-treated ring were exposed to 10~8 M prostacyclin which caused relaxation (by 14 ± 4% in control rings, and 27 ± 5% in indomethacin-treated rings). When the effect of prostacyclin had stabilized (approximately 3 minutes), increasing concentrations (10~9 to 10~7 M) of isoproterenol were given (Fig. 6 ). Prostacyclin significantly reduced the relaxation induced by 3 X 10" 9 to 10~8 M isoproterenol (Fig. 6) . Indomethacin significantly augmented the relaxations to all doses of isoproterenol (Fig. 6) ; this augmentation was abolished by prostacyclin (Fig. 6) .
The prostacyclin synthetase inhibitor tranylcypromine (10~4 M) augmented basal tension (by 1.0 ± 0.5 g; n = 5) and prostaglandin F 2a -induced contraction (7.2 ± 0.6 g; n = 5). It significantly reduced the relaxation to isoproterenol in the concentration range of 3 X 10" 9 -3 X 10" 7 M (Fig. 7) . Exogenous prostaglandin E 2 induced concentration-dependent (10~7 to 10~5 M) increases in isometric tension of intact coronary artery rings. At a concentration of 10" 6 M, prostaglandin E 2 evoked concentrations (4.2 ± 0.4 g; n = 5) comparable to those induced by 2 X 10~6 M of prostaglandin F 2a ; the relaxations to increasing concentrations of isoproterenol (10~9 to 10 6 M) were significantly depressed ( Fig. 7) . A similar depression of /3-adrenergic responsiveness was noted during contractions (5.6 ± 0.4 g; n = 7) caused by the combination of prostaglandin F 2a (2 X 10~6 M) and E 2 (2 X 10" 7 M) ( Fig. 7) .
Rings contracted with prostaglandin F 2a were treated with isobutyl-methylxanthin (IBMX; 10~6 M). IBMX reduced the contractions (by 12 ± 4%) and • = Control 0= Indomethacin. 9 x 10' 8 M A= Sodium meclofenamate. 10' 5 M A-ASA. 5 x 10 5 M significantly augmented the relaxation caused by isoproterenol, both in the absence and presence of indomethacin ( Fig. 8) .
FIGURE 4. Effect of various cyclooxygenase inhibitors [indomethacin, sodium meclofenamate, and acetylsalicylic acid (ASA)] on responses to norepinephrine (left) and isoproterenol (right) in canine coronary arteries contracted with KCI. Results are expressed as percent of the response to 2 x 10~2 M KCI. Symbols represent means ± SEM of five experiments. Control responses and those in the presence of antagonists were obtained simultaneously in four separate rings from the same dogs. The differences shown between responses to norepinephrine and isoproterenol in the absence or presence of cyclooxygenase inhibitors were statistically significant (P < 0.05), except at higher concentrations of isoproterenol (10~6 to 10~* M) in the presence of acetylsalycilic acid.
[ 3 H]Norepinephrine Overflow
In superfused left circumflex coronary artery strips, previously incubated with [ 3 H]norepinephrine, transmural electrical stimulation at 2 Hz for 6° Isoproterenol, -logM FIGURE 6. Effect of exogenous prostacyclin on ^-adrenergic relaxation in response to isoproterenol in canine coronary arteries contracted with prostaglandin F 2a (2 x 10' 6 M) in the absence and the presence of indomethacin (5 X 10' 6 M). Symbols represent the mean ± SEM of rings taken from five dogs. Control responses and those in the presence of prostacyclin and indomethacin were obtained simultaneously in four separate rings from the same dog. minutes (Si) evoked an increase in tritium and [ 3 H]norepinephrine overflow, but caused no change in basal tone of quiescent coronary artery strips (Fig.  9) . A repeated stimulation (S 2 ) after 48 minutes of superfusion with physiological salt solution caused smaller increases in tritium and [ 3 H]norepinephrine overflow (Fig. 9 ). In paired strips from the same coronary arteries studied in parallel, indomethacin (5 X 10~6 M; started 8 minutes after Si) augmented basal tension but did not alter the fractional release FIGURE 8. Effect of the phosphodiesterase inhibitor drug  isobutyl-methylxanthine (IBMX; 10~6 M) on isoproterenolinduced relaxations of canine coronary arteries contracted  with prostaglandin F 2 « (2 X 10~6 M), in the absence (left)  and presence (right) of indomethacin (5 X lCT* M). Symbols  represent the mean ± SEM of rings taken from four dogs.  Control responses and those in the presence of inhibitors  were obtained in four separate rings from the same dog. of tritium or the [ 3 H]norepinephrine overflow under basal conditions or with repeated electrical stimulation ( Fig. 9 ; Table 1 ). The ratio of S 2 :Si in the presence of indomethacin was comparable to that obtained in its absence (Table 1) . Similarly, indomethacin had no effect on basal or stimulationevoked overflow of metabolites of norepinephrine (Table 1) .
Discussion
The present study shows that indomethacin augments /3-adrenergic relaxation caused by endogenous norepinephrine released by electrical stimulation of isolated canine coronary arteries, and demonstrates that these findings cannot be explained by basal conditions and during electrical stimulation (10 V, 0.2 msec, 2  Hz for 6 minutes) of superfused canine coronary arteries. Control  responses and those in the presence of indomethacin were obtained  simultaneously in two separate strips from the same dog. Superfusate,  contained indomethacin (5 x 10~6 M) 40 minutes prior to the second  stimulation period. a prejunctional action of the drug. Indeed, indomethacin does not affect basal or stimulationevoked overflow of [ 3 H]norepinephrine, excluding the possibility that it facilitates the release of transmitter. Similarly, the fact that indomethacin did not influence the basal or stimulation-evoked overflow of the major metabolites of norepinephrine rules out the possibility that the drug enhances /3-adrenergic relaxation because it inhibits the disposition of the released transmitter from the junctional cleft. Thus, indomethacin augments relaxation of canine coronary arteries during activation of the sympathetic nerve endings by acting at the postjunctional level. This conclusion is strengthened by the observed effects of indomethacin on the response to exogenous norepinephrine, during contractions evoked by prostaglandin F 2tt .
FIGURE 9. Effect of indomethacin on tension, fractional release of tritiated compounds, and overflow of intact [ 3 H]norepinephrine under
In rings contracted with 20 IHM KC1 exogenous norepinephrine causes contraction rather than relaxation. Under normal conditions, the /8-adrenergic effects of catecholamines predominate in coronary smooth muscle (Zuberbuhler and Bohr, 1965; Seidel et al., 1975; Cohen et al., 1983) . However, during hypoxia (Borda et al., 1980) or ischemia (Moore and Parratt, 1975; Barcia et al., 1976; Vatner et al., 1977) , the a-adrenergic component of their action, for unknown reasons, is augmented and overrules the (8-adrenergic relaxation. The present experiments demonstrate, for norepinephrine, that a similar reversal from relaxation to contraction occurs when the coronary smooth muscle is exposed to high K + . As myocardial hypoxia and ischemia cause accumulation of K + in the extracellular fluid (Benzing et al., 1971; Schuchleib et al., 1976; Downar et al., 1977) , the paradoxical response to norepinephrine observed in the present studies in coronary rings contracted with K + may explain the reversal obtained in vivo in the hypoxic or ischemic heart. The present findings do not allow a conclusion as to the nature of the cellular mechanism underlying the K +induced reversal from /?-to a-adrenergic predomi- Results are expressed as means ± SEM (n = 5). A abbreviations: NE, norepinephrine; MOPEG, 3 methoxy, 4 hydroxyphenylglycol; VMA, 3-methoxy, 4-hydroxymandelic acid; NMN, normetanephrine; DOMA, 3, DOPEG, 3, * Results are given as percent fractional release of tritium ( 3 H) during 6-minute superfusion before (basal) or after (stimulation) electrical stimulation.
t S2/S1 = the ratio between the overflow of 3 H or 3 H-norepinephrine evoked by S2 and that evoked by Si. % Results are given as dpm/15 ml superfusate (see Methods) collected for 6 minutes before (basal) and after (stimulation) electrical stimulation.
§ Superfusion with physiological salt solution (control) or with solution containing indomethacin (5 X 10~6 M). || Transmural electrical stimulation: 10 V, 0.2 msec at 2 Hz for 6 minutes.
nance. One explanation would be that the high K + causes inhibition of Na + ,K + -ATPase (Webb and Bohr, 1980; Cooke et al., 1984) . The observation that inhibitors of cyclooxygenase reverse the effect of norepinephrine during contractions evoked by K + from contraction to relaxation, strongly suggests that endogenous prostanoids play an important role as well.
Postjunctional augmentation of relaxations induced by catecholamines in the presence of indomethacin could be explained if the drug were to inhibit the a-adrenergic activation of the coronary smooth muscle by the adrenergic transmitter (Zuberbuhler and Bohr, 1965; Feigl, 1968; Vatner et al., 1970; Seidel et al., 1975; Heyndrickx et al., Cohen et al., 1983) . This interpretation is supported by the fact that a-adrenoceptor blockade with phentolamine (Seidel et al., 1975; Cohen et al., 1983) reverses the response to norepinephrine in arteries contracted with depolarizing solution. However, the fact that it is unlikely that indomethacin has an effect on a-adrenoceptors results from the following observations: (1) after pretreatment with propranolol, norepinephrine evoked comparable a-adrenergically mediated contractions in the absence and presence of indomethacin, and (2) indomethacin augmented the relaxation caused by the /3-adrenoceptor agonist isoproterenol. The present findings in the canine coronary artery differ from the observations in rabbit kidney where one of the end-products of cyclooxygenase pathway, prostacyclin, was shown to inhibit a-adrenergic vasoconstriction postjunctionally (Hedqvist, 1979) .
Another explanation for the augmented /3-adrenergic relaxation would be that indomethacin acts as a phosphodiesterase inhibitor (Flores and Sharp, 1972; Flower, 1974) . /3-Adrenergically mediated re-laxations of coronary arteries can be augmented by inhibitors of phosphodiesterase (Siedel et al., 1975; Kukovetz et al., 1981) . However, the present finding that the phosphodiesterase inhibitor drug isobutylmethylxanthine was equally potent in augmenting /3-adrenergic relaxations in the absence and the presence of indomethacin, may argue against this possibility. This conclusion is strengthened considerably by the fact that other inhibitors of cyclooxygenase, without inhibiting properties on phosphodiesterase, also augment /3-adrenergic responsiveness in the canine coronary artery.
Since indomethacin augmented the contraction caused by prostaglandin F 2a , the change in active tone rather than the inhibition of prostaglandin synthesis may result in augmentation of /3-adrenergic relaxations. The following findings refute this possibility: (1) /3-adrenergic responsiveness was increased by indomethacin and other cyclooxygenase inhibitors in K + -depolarized rings, despite the fact that the inhibitors of prostaglandin synthesis did not augment KCl-induced contractions; and (2) sodium nitroprusside-or acetylcholine-evoked relaxations were not affected by indomethacin in prostaglandin F 2a -contracted rings despite the augmentation of the contractile response. Thus, the most logical explanation for the postjunctional effect of indomethacin (and other cyclooxygenase inhibitors) is that the augmentation of /3-adrenergically mediated coronary relaxation is due to inhibition of the synthesis of endogenous prostaglandins.
In isolated canine, porcine, and bovine coronary arteries, hypoxia, which stimulates prostaglandinsynthesis in the coronary artery wall (Kalsner, 1977; Roberts et al., 1981) , inhibits /3-adrenergically mediated relaxation (Borda et al., 1980) . Exogenous prostaglandins inhibit, while inhibition of endoge-nous prostaglandin synthesis augments, coronary vasodilation caused by electrical stimulation of the adrenergic nerves and exogenous catecholamines in isolated cat hearts (Sunahara and Talesnik, 1974) . These observations, taken in conjunction with the facilitatory action of three inhibitors of cyclooxygenase, strongly support the hypothesis that prostanoids generated within the coronary arterial wall exert a "braking" effect on /3-adrenergic responsiveness.
The augmentation of basal tension by the cyclooxygenase inhibitors indicates that, in the canine cornary artery preparations, the dominant cyclooxygenase end-product is a vasodilator prostaglandin, most probably prostacyclin (Kalsner, 1977; Needleman and Isakson, 1980; Roberts et al., 1981) . The prostacyclin synthetase inhibitor, tranylcypromine, and cyclooxygenase inhibitors caused comparable augmentations of basal tension and contractions induced by prostaglandin F 2n . Exogenous prostacyclin abolishes the effect of indomethacin. These observations may suggest that endogenous prostacyclin is responsible for the reduction in /3-adrenergic responsiveness. However, tranylcypromine depressed, rather than augmented, 0-adrenergic relaxations. The other two major pharmacological actions of tranylcypromine, inhibition of monoamine-oxidase (Vanhoutte and Shepherd, 1969) and antagonism of a 2 -adrenoceptors (unpublished observations) should enhance rather than depress the inhibitory effect of catecholamines. Thus, cyclooxygenase products other than prostacyclin may also be involved in the blunting of /3-adrenergic responsiveness, especially when prostacyclin synthesis is inhibited. A likely candidate would be prostaglandin E 2 , whose production may be increased in the presence of tranylcypromine. This prostanoid inhibits metabolic coronary vasodilatation in the perfused heart (Sunuhara and Talesnik, 1974) . Furthermore, in the present study, exogenous prostaglandin E 2 depressed /3-adrenergic responsiveness.
The inhibitory effect of the metabolite(s) of arachidonic acid on /3-adrenergically mediated relaxation could be of importance in the pathogenesis of vasospasm of large coronary arteries (Maseri et al., 1979; Hillis and Braunwald, 1978; Sparks and Gorman, 1981) , as it would favor a-adrenergic coronary vasoconstriction. This would be the case, in particular, under conditions (e.g., hypoxia or ischemia) when endogenous prostaglandin biosynthesis is accelerated (Berger et al., 1970; Kalsner, 1977; Needleman, et al., 1977; Roberts et al., 1981) the local release of norepinephrine is increased (Borda et al., 1980) , and the main effect of catecholamines is shifted from /3-adrenergic to a-adrenergic predominance (Moore and Parratt, 1973; Barcia et al., 1976; Vatner et al., 1977) . These findings in isolated coronary arteries may help to explain why, in intact cats and dogs, hypoxia and ischemia inhibit coronary vasodilation evoked by /3-adrenoceptor stimulation.
